CMND
Clearmind Medicine Inc.
1W: +6.4%
1M: -37.9%
3M: -72.2%
YTD: -63.8%
1Y: -98.4%
3Y: -100.0%
$0.72
+0.05 (+7.78%)
After Hours: $0.71 (-0.01, -1.39%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.595-52.4
Volume41,905
Avg Volume257,632
Beta-1.05
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAdi Zuloff-Shani
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2022-11-15
Websiteclearmindmedicine.com
1220 West 6th Avenue
Vancouver, BC V6H 1A5
CA
Vancouver, BC V6H 1A5
CA
604 260 1566
About Clearmind Medicine Inc.
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Latest News
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Lamadrid David | A-Award | 857,143 | $0.35 | 2017-05-12 |
| Lamadrid David | 0 | — | 2017-05-01 | |
| Lamadrid David | 0 | — | 2017-05-01 | |
| Lamadrid David | 0 | — | 2017-05-01 |